Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ANIKANIK
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ANIKA THERAPEUTICS INC

Yes. Goldman Sachs holds 237,722 shares of ANIK (Anika Therapeutics), worth $3.5M, as of its Q2 2026 13F filing. It increased the position by 19,844 shares (+9.1%) from Q1 2026. Goldman Sachs has held ANIK in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$3.5M

Current Shares

237,722

Total Value Change

+$180,873

Total Shares Change

+90,025

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
237,722
+9.1%
$3.5M0.0%$14.63
29
2026-Q1
Increased
217,878
+32.1%
$3.2M0.0%$14.50
34
2025-Q4
Increased
164,926
+153.8%
$1.6M0.0%$9.61
41
2025-Q3
Increased
64,975
+150.4%
$610,7650.0%$9.40
39
2025-Q2
Decreased
25,945
-50.1%
$274,4980.0%$10.58
0
2025-Q1
Decreased
51,984
-24.3%
$781,3200.0%$15.03
0
2024-Q4
Decreased
68,685
-22.6%
$1.1M0.0%$16.46
0
2024-Q3
Increased
88,727
+18.5%
$2.2M0.0%$24.70
31
2024-Q2
Decreased
74,857
-2.7%
$1.9M0.0%$25.33
0
2024-Q1
Decreased
76,930
-4.7%
$2M0.0%$25.40
0
2023-Q4
Decreased
80,742
-2.1%
$1.8M0.0%$22.66
0
2023-Q3
Increased
82,504
+36.8%
$1.5M0.0%$18.63
33
2023-Q2
Increased
60,291
+20.3%
$1.6M0.0%$25.98
30
2023-Q1
Increased
50,106
+8.0%
$1.4M0.0%$28.72
28
2022-Q4
Decreased
46,395
-31.8%
$1.4M0.0%$29.60
0
2022-Q3
Decreased
68,028
-53.9%
$1.6M0.0%$23.80
0
2022-Q2
First report
147,697
-
$3.3M0.0%$22.32
0

Other major holders of ANIK: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used